New Frontiers in the Treatment and
Management of Chronic Cough: A Closer Look at the Role of Emerging
A continuing medical education
activity provided by NAMCP and AAMCN
This activity is an archive from the live session from the 2020 Fall
Managed Care Forum. If you participated in the live session, you are
not eligible for continuing education credits from this archive.
This activity is valid from November 1, 2020 to March 1, 2022
Instructions for CME/NCPD: Complete the pre-test, listen to the
audio and view the slides, complete the post test, complete the
evaluation form and hit submit. You will be asked to enter your name
and email address on the pre-test, evaluation and post-test. If you
close your internet browser without completing the post test, you
will have ONE more opportunity to complete. A score of 70% must be
achieved on the post test to receive continuing education credits.
If you do not pass the post test after two attempts, you will not be
eligible to try again. Once you complete the evaluation form and
score 70% or higher on your post test, you will automatically be
given your certificate.
To print or save your certificate, you will need to click on the
“download” button and either print or save.
This activity is intended for healthcare professionals practicing in
managed care environments.
This activity is supported by
educational grants from
Merck Sharp & Dohme Corp.
Chronic cough, which is observed in approximately 12% of the US
population, is defined as a cough that lasts for more than 8 weeks.
Patients with chronic cough are often distressed by the condition,
which can lead to depression, anxiety, a decline in quality of life,
and changes to their social activities. The diagnosis and management
of chronic cough can be challenging, with only approximately 50% of
patients receiving a diagnosis. Recent advances have been made in
the understanding and management of refractory chronic cough, with
several novel therapies being evaluated in ongoing clinical studies.
This educational activity will review the burden of chronic cough,
discuss the current recommendations for the management of patients
with chronic cough, and evaluate the latest clinical data regarding
emerging pharmacotherapies for the treatment of patients with
refractory chronic cough.
Upon completion of this
activity, participants will be able to:
Review the clinical and economic
burden of chronic cough, particularly in patients who do not
find relief from recommended management strategies
Evaluate the current recommendations
for the management of patients with chronic cough and the unmet
Analyze the mechanisms of action as
well as the latest clinical data regarding emerging
pharmacotherapies to treat patients with refractory chronic
Examine the emerging role of P2X3
receptor antagonists in the management of refractory or
unexplained chronic cough
||Michael S. Blaiss, MD
Executive Medical Director
American College of Allergy, Asthma, and Immunology
Physician, Good Samaritan Health Clinic of East Gwinnett
Clinical Professor of Pediatrics
Medical College of Georgia at Augusta University
serves as a consultant for Bellus and Merck His
presentation has been peer reviewed for any bias.
MD has no real or perceived financial relationships to
Jeremy Williams has no real or perceived financial
relationships to disclose.
Jacqueline Cole, RN, MS, CMCN has no real or perceived
financial relationships to disclose.
NAMCP and/or the presenter
has copyright or has received permissions for use of
materials provided in this activity.
Accreditation & Designation
This activity has been planned and implemented in accordance with
the accreditation requirements and policies of the Accreditation
Council for Continuing Medical Education (ACCME) through the joint
providership of the National Association of Managed Care Physicians
(NAMCP) and American Association of Managed Care Nurses (AAMCN). The
National Association of Managed Care Physicians is accredited by the
ACCME to provide continuing medical education for physicians.
NAMCP designates this enduring material for a maximum of 1 AMA
PRA Category 1 credit(s)TM. Each
physician should claim credit commensurate with the extent of their
participation in the activity.
The American Association of Managed Care Nurses is accredited as a
provider of nursing continuing professional development by the
American Nurses Credentialing Center's Commission on Accreditation.
Nurses who complete this activity and achieve a passing score will
receive 1 hour in nursing continuing professional development.
This activity has been approved by the American Board of Managed
Care Nursing for 1.0 contact hours toward CMCN recertification
This activity is supported by educational grants from
Merck Sharp & Dohme Corp.
NAMCP and/or this website does not
provide medical advice, diagnosis or treatment. NAMCP does not
endorse or imply endorsement of the content on any linked website.
This website is to be used as an informational resource. With any
health related concern, consult with your physician or healthcare
Click Here To Continue